Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
2011

Link Between Mycoplasma and Prostate Cancer

Sample size: 219 publication Evidence: moderate

Author Information

Author(s): Cydney Urbanek, Steve Goodison, Myron Chang, Stacy Porvasnik, Noburo Sakamoto, Chen-zhong Li, Susan K Boehlein, Charles J Rosser

Primary Institution: The University of Florida

Hypothesis

Is there a connection between Mycoplasma hyorhinis exposure and prostate cancer?

Conclusion

The study suggests that exposure to Mycoplasma hyorhinis may be linked to the development of prostate cancer.

Supporting Evidence

  • 36% of men with benign prostatic hyperplasia had antibodies to M. hyorhinis.
  • 52% of men with prostate cancer had antibodies to M. hyorhinis.
  • The study used a novel indirect ELISA to detect antibodies.

Takeaway

The study found that more men with prostate cancer had antibodies to a specific bacteria compared to men with a non-cancerous prostate condition.

Methodology

Serum samples from men with prostate cancer and benign prostatic hyperplasia were tested for antibodies to M. hyorhinis using an indirect ELISA.

Potential Biases

The control group was not ideal as it included men with benign prostate conditions.

Limitations

The study had a small, selected cohort and did not confirm M. hyorhinis presence in the prostate tissue.

Participant Demographics

Men aged 30-86, with a mix of races including White and African American.

Statistical Information

P-Value

0.014

Statistical Significance

p = 0.014

Digital Object Identifier (DOI)

10.1186/1471-2407-11-233

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication